Cell Biology of Autoimmune Diseases

International Review of Cytology

Volumn 178, Issue , 1997, Pages 127-206

  Van Noort, Johannes M ^a,b   Amor, Sandra ^a,b  

^a TNO   (Netherlands)

^b ST THOMAS HOSPITAL   (United Kingdom)

Author keywords

Allergic encephalomyelitis; Autoimmune diseases; Autoreactive T lymphocytes; Immune therapy; Multiple sclerosis; Stress proteins

Indexed keywords

AUTOIMMUNITY; CYTOLOGY; HUMAN; INFLAMMATION; INSULIN DEPENDENT DIABETES MELLITUS; MULTIPLE SCLEROSIS; NONHUMAN; PRIORITY JOURNAL; REVIEW; RHEUMATOID ARTHRITIS; T LYMPHOCYTE; T LYMPHOCYTE ACTIVATION;

ANIMALIA;

EID: 0030662466     PISSN: 00747696     EISSN: None     Source Type: Book Series    
DOI: 10.1016/s0074-7696(08)62137-3     Document Type: Article

References (158)

1. Acha-Orbea, H., Mitchell, S. J., Timmermann, L., Wraith, D. C, Tausch, G. S., Waldor, M. K., Zamvil, S. S., McDevit, H. O., and Steinman, L. (1988). Limited heterogeneity of T-cell receptors from lymphocytes mediating autoimmune encephalomyelitis allows specific immune intervention. Cell (Cambridge, Mass.) 54, 263-273.
2. Agranoff, B. W., and Goldberg, D. (1974). Diet and the geographical distribution of multiple sclerosis. Lancet 2, 1061-1066.
3. Albani, S., and Carson, D. A. (1996). A multistep molecular mimicry hypothesis for the pathogenesis of rheumatoid arthritis. Immunol. Today 17(10), 466-470.
4. Alter, M., Yamoor, M., and Harshe, M. (1974). Multiple sclerosis and nutrition. Arch. Neural. (Chicago) 31, 267-272.
5. Amor, S., and Webb, H. E. (1988). CNS pathogenesis following dual virus infection with Semliki Forest (alphavirus) and Langat (flavivirus). Br. J. Exp. Pathol. 69,197-208.
6. Amor, S., Baker, D., Groome, N., and Turk, J. L. (1993). Identification of a major encephalitogenic epitope of proteolipid protein (residues 56-70) for the induction of experimental allergic encephalomyelitis induction in Biozzi AB/H and non-obese diabetic mice. J. Immunol. 150, 5666-5672.
7. Amor, S., Groome, N., Linington, C, Morris, M. M., Dornmair, K., Gardinier, M. V., Matthieu, J.-M., and Baker, D. (1994). Identification of epitopes of myelin associated glycoprotein for the induction of experimental allergic encephalomyelitis in SJL and Biozzi AB/H mice. J. Immunol. 153, 4349-4356.
8. g7) mice share an amino acid motif. J. Immunol. 156, 3000-3008.
9. Amor, S., Scallan, M. F., Morris, M. M., Dyson, H., and Fazakerely, J. K. (1996b). Role of immune responses in protection and pathogenesis during Semliki Forest virus encephalitis. J. Gen. Virol. 77, 281-291.
10. Anderton, S. M., and Van Eden, W. (1996). T-lymphocyte recognition of hsp 60 in experimental arthritis. In "Stress Proteins in Medicine" (W. Van Eden, and D. Young, eds.), pp. 73-91. Dekker, New York.
11. Bajramovic, J. J., Lassmann, H., and Van Noort, J. M. (1997). Expression of alpha B-crystallin during lesional development in multiple sclerosis. J. Neuroimmimol. (in press).
12. Baker, D., O'Neill, J. K., Gschmeissner, S. E., Wilcox, C. E., Butter, C, and Turk, J. L. (1990). Induction of chronic relapsing experimental allergic encephalomyelitis in the Biozzi ABH mouse. J. Neiiroimmimol. 28, 261-265.
13. Baker, D., Butler, D., Scallon, B. J., O'Neill, J. K., Turk, J. L., and Feldmann, M. (1994). Control of experimental allergic encephalomyelitis by inhibition of tumour necrosis factor (TNF) activity within the central nervous system using monoclonal antibodies and TNF receptor-immunoglobulin fusion proteins. Eur. J. Immunol. 24, 2040-2048.
14. Baker, D., Rosenwasser, O. A., O'Neill, J. K., and Turk, J. L. (1995). Genetic analysis of experimental allergic encephalomyelitis in mice. J. Immunol. 55, 4046-4051.
15. Baum, H., Davies, H., and Peakman, M. (1996). Molecular mimicry in the MHC: Hidden clues to autoimmunity. Immunol. Today 17, 64-70.
16. Ben-Nun, A., Wekerle, H., and Cohen, I. R. (1981). Vaccination against autoimmune encephalomyelitis with T-lymphocyte line cells reactive against myelin basic protein. Nature (London) 292, 60-61.
17. Betz, A. L. (1993). Oxygen free radicals and the brain microvasculature. In 'The Blood Brain Barrier' (W. M. Pardridge, ed.), pp. 303-321. Raven Press, New York.
18. Blalock, J. E. (1994). The syntax of immune-neuroendocrine communication. Immunol. Today 15, 504-511.
19. Boitard, C, and Bach, D. E. (1991). Insulin-dependent diabetes mellitus: An autoimmune disease. In 'Molecular Autoimmunity' (N. Talal, ed.), pp. 273-318. Academic Press, London.
20. Brocke, S., Gaur, A., Piercy, C., Gautam, A., Gijbels, K., Garrison Fathman, C., and Steinman, L. (1993). Induction of relapsing paralysis in experimental autoimmune encephalomyelitis by bacterial superantigen. Nature (London) 365, 642-644.
21. Brodsky, F. M., and Guagliardi, L. E. (1991). The cell biology of antigen processing and presentation. Annu. Rev. Immunol. 9, 707-744.
22. Bureau, J. F., Montagutelli, X., Bihl, F., Lefebvre, S., Guenet, J. L., and Brahic, M. (1993). Mapping loci influencing the persistence of Theiler's virus in the murine central nervous system. Nat. Genet. 5, 87-91.
23. Butcher, E. C., and Picker, L. J. (1996). Lymphocyte homing and homeostasis. Science 272, 60-66.
24. Cammer, W., Bloom, B. R., Norton, W. T., and Gordon, S. (1978). Degradation of basic protein in myelin by neutral proteases secreted by stimulated macrophages: A possible mechanism of inflammatory demyelination. Proc. Natl. Acad. Sei. U.S.A. 75, 1554-1558.
25. Cannella, B., and Raine, C. S. (1995). The adhesion molecule and cytokine profile of multiple sclerosis lesions. Ann. Neural. 37, 424-435.
26. Car, B. D., Eng, V. M., Schnyder B., LeHir, M., Shahkov, A. N., Woerly, G., Huang, S., Aguet, M., Anderson, T. D., and Ryffel, B. (1995). Role of interferon-γ- in IL-2-induced pathology in mice. Am. J. Pathol. 147, 1693-1707.
27. Cawston, T. E. (1996). Metalloproteinase inhibitors and the prevention of connective tissue breakdown. Pharmacol. Ther. 70, 163-182.
28. Chen, Y., Inobe, J.-I., Marks, R., Gonnella, P., Kuchroo, V. K., and Weiner, H. L. (1995). Peripheral detection of antigen-reactive T cells in oral tolerance. Nature (London) 376, 177-180.
29. Cohen, I. R. (1996). Heat shock protein 60 and the regulation of autoimmunity. In "Stress Proteins in Medicine" (W. Van Eden and D. Young, eds.), pp. 73-91. Dekker, New York.
30. Conrad, B., Weidmann, E., Trucco, G., Rudert, W. A., Behboo, R., Ricordi, C, Rodriguez-Rilo, H., Finegold, D., and Trucco, M. (1994). Evidence for superantigen involvement in insulin-dependent diabetes mellitus aetiology. Nature (London) 371, 351-355.
31. Croft, M. L., Bradley, L. M., and Swain, S. L. (1994). Naive versus memory CD4 T cell responses to antigen: Memory cells are less dependent on accessory cell costimulation and can respond to many antigen-presenting cell types including B cells. J. Imunol. 152, 2675-2685.
32. 14C-labeled cells during acute, chronic, and relapsing experimental allergic encephalomyelitis. Lab. Invest. 63(2), 162-170.
33. Crowe, P. D., Walter, B. N., Mohler, K. M., Otten-Evans, C., Black, R. A., and Ware, C. F. (1995). A metalloproteinase inhibitor blocks shedding of the 80-kD TNF receptor and TNF processing in lymphocytes. J. Exp. Med. 81, 1205-1210.
34. Cupps, T. R., and Fauci, A. S. (1982). Corticosteroid-mediated immunoregulation in man. Immunol. Rev. 65, 133-155.
35. Dalgleish, A. G. (1995). The immune response to HIV: Potential for immunotherapy. Immunol. Today 16, 356-358.
36. Dalgleish, A. G., Fazakerely, J. K., and Webb, H. E. (1987). Do human T-lymphotropic viruses (HTLVs) and other enveloped viruses induce autoimmunity in multiple sclerosis? Neuropallwl. Appl. Neurobiol. 13, 241-250.
37. Davies, J. L., Kawaguchi, Y., and Bennett, S. T. (1994). A genome-wide search for human type-1 diabetes susceptibility genes. Nature (London) 371, 130-136.
38. De Graeff-Meeder, E. R., Van der Zee, R., Rijkers, G. T., Schuurman, H.-J., Kuis, W., Bijlsma, J. W. J., Zegers, B. J. M., and Van Eden, W. (1991). Recognition of the human 60 kD heat shock protein by mononuclear cells from patients with juvenile chronic arthritis. Lancet 337,1368-1370.
39. Del Pozo, M. A., Sanchez, Mateo, P., and Sanchez-Madrid, F. (1996). Cellular polarization induced by chemokines: A mechanism for leukocyte recruitment? ImmunoL Today 17, 127-130.
40. Dubois-Dalq, M., Niedieck, B., and Buyse, M. (1970). Action of anti-cerebroside sera on myelinated nervous tissue cultures. Palhologica 5, 331-347.
41. Ebers, G. C. et al. (1996). A full genome search in multiple sclerosis. Nat. Genet. 13,472-476.
42. Elliot, M. J., and Maini, R. N. (1996). What are the prospects for therapy based on cytokines and anti-cytokines in rheumatoid arthritis? In "Cytokines and Autoimmunity" (F. M. Brennan and M. Feldmann, eds.), pp. 239-256. R. G. Landes Co., Austin, TX, Chapman & Hall, London.
43. Enari, M., Talanian, R., Wong, W., and Nagata, S. (1996). Sequential activation of ICE-like and CPP32-like proteases during Fas-mediated apoptosis. Nature (London) 380, 723-726.
44. Fairchild, P. J., and Wraith, D. C. (1996). Lowering the tone: Mechanisms of immunodominance among epitopes with low affinity for MHC. Immunol. Today 17, 80-85.
45. Fazakerley, J. K., Amor, S., and Nash, A. A. (1997). Animal model systems of MS. In "Molecular Biology of Multiple Sclerosis" (W. C. Russell, ed.), pp. 255-273. Wiley, Chichester.
46. Fisher, H. P., Sharrock, C. E., and Panayi, G. S. (1992). High frequency of cord blood lymphocytes against the mycobacterial 65-kDa heat-shock protein. Eur. J. Immunol. 22, 1667-1672.
47. Ford, A. L., Foulcher, E., Lemckert, F. A., and Sedgwick, J. (1996). Microglia induce CD4 T lymphocyte final effector function and death. J. Exp. Med. 184, 1737-1745.
48. Fujinami, R. S., and Oldstone, M. B. A. (1985). Amino acid sequence homology between the encephalitogenic site of myelin basic protein and virus: Mechanisms for autoimmunity. Science 230,1043-1045.
49. Fukaura, H., Kent, S. C, Pietrusewicz, M. J., Khoury, S. J., Weiner, H. L., and Hafler, D. A. (1996). Induction of circulating myelin basic protein and proteolipid protein specific transforming growth factor β1-secreting T cells by oral administration of myelin in multiple sclerosis patients. . Clin. Invest. 98, 70-77.
50. Gaur, A., Wiers, B., Liu, A., Rothbard, J., and Fathman, G. C. (1992). Amelioration of autoimmune encephalomyelitis by myelin basic protein synthetic peptide-induced anergy. Science 258, 1491-1493.
51. Gearing, A. J., Beckett, P., Chrostodoulou, M., and Churchill, M. (1994). Processing of tumour necrosis factor-α precursor by metalloproteinases. Nature (London) 370, 555-557.
52. Germain, R. N. (1994). MHC-dependent antigen processing and peptide presentation: Providing ligands for T lymphocyte activation. Cell (Cambridge, Mass.) 76, 287-299.
53. Gerritse, K., Laman, J. D., Noelle, R. J., Arruffo, A., Ledbetter, J. A., Boersma, W. J. A., and Claassen, E. (1996). CD4-CD40 ligand interactions in experimental allergic encephalo-myelitis and multiple sclerosis. Proc. Natl. Acad. Sei. U.S.A. 93, 2499-2504.
54. Gianani, R., and Sarvetnik, N. (1996). Viruses, cytokines, antigens and autoimmunity. Proc. Natl. Acad. Sei. U.S.A. 93, 2257-2259.
55. Glabinski, A., Tawsek, N. S., and Bartosz, G. (1993). Increased generation of Superoxide radicals in the blood of MS patients. Ada Neural. Scand. 88, 174-177.
56. Goverman, J., Woods, A., Larson, L., Weiner, L. P., Hood, L., and Zaller, D. M. (1993). Transgenic mice that express a myelin basic protein-specific T cell receptor develop spontaneous autoimmunity. Cell (Cambridge, Mass.) 72, 551-560.
57. Griffith, T. S., Brunner, T., Fletcher, S. M., Green, D. R., and Ferguson, T. A. (1995). Fasligand induced apoptosis as a mechanism of immune privilege. Science 270, 1189-1192.
58. Hafler, D. A., Benjamin, D. S., Burks, J., and Weiner, H. L. (1987). Myelin basic protein and proteolipid protein reactivity of brain- and cerebrospinal fluid-derived T cell clones in multiple sclerosis and postinfectious encephalomyelitis. J. Immunol. 139, 68-72.
59. Halliwell, B., and Gutteridge, J. M. C. (1984). Oxygen toxicity, oxygen radicals, transition metals and disease. Biochem. J. 219, 1-14.
60. Harbige, L. S. (1996). Nutrition and immunity with emphasis on infection and autoimmune disease. Nutr. Health 10, 285-312.
61. Harding, C. V., and Unanue, E. R. (1990). Cellular mechanisms of antigen processing and the function of class I and class II major histocompatibility molecules. Cell Regul. 1,499-509.
62. Harding, F. A., McArthur, J. G., Gross, J. A., Raulet, D. H., and Allison, J. P. (1992). CD28-mediated signalling costimulates murine T cells and prevents induction of anergy in T-cell clones. Nature (London) 356, 607-609.
63. Hashimoto, L. et al. (1994). Genetic mapping of a susceptibility locus for insulin-dependent diabetes mellitus on chromosome llq. Nature (London) 371, 161-164.
64. He, C, Wilhelm, S. M., Pentland, A. P., Marmer, B. L., Grant, G. A., Eisen, A. Z., and Goldberg, G. I. (1989). Tissue cooperation in a proteolytic cascade activating human interstitial collagenase. Proc. Natl. Acad. Sei. U.S.A. 86, 2632-2636.
65. Held, W., Ache-Orbea H., MacDonald, H., and Waanders, G. A. (1994). Superantigens and retroviral infection: Insites from mouse mammory tumor virus. Immunol. Today 15,184-190.
66. Hickey, W. F., Hsu, B. L., and Kimura, H. (1991). T-lymphocyte entry into the central nervous system. J. Nenrosci. Res. 28, 254-260.
67. Higgins, P. J., and Weiner, H. L. (1988). Suppression of experimental autoimmune encephalomyelitis by oral administration of myelin basic protein and its fragments. J. Immunol. 140,440-448.
68. Ibrahim, M. A. A., Chain, B. M., and Katz, D. R. (1995). The injured cell: The role of the dendritic cell system as a sentinel receptor pathway. Immunol. Today 16, 181-186.
69. Janeway, C. A., Jr. (1992). The immune system evolved to discriminate infectious nonself from noninfectious self. Immunol. Today 13,11-16.
70. Jenkins, M. K. (1994). The ups and downs of costimulation. Immunity 1, 443-446.
71. Ju, S.-T., Panka, D., Cul, H., Ettinger, R., El-Khabib, M., Sherr, D., Stanger, B., and Marshak-Rothstein, A. (1995). Fas (CD95)/FasL interactions required for programmed cell death after T-cell activation. Nature (London) 373, 444-448.
72. Khoury, S. J., Hancock, W. W., and Weinder, H. L. (1992). Oral tolerance to myelin basic protein and natural recovery from experimental allergic encephalomyelitis are associated with downregulation of inflammatory cytokines and differential upregulation of transforming growth factor, interleukin 4 and prostaglandin E expression in the brain. J. Exp. Med. 176,1355-1364.
73. Kotb, M. (1995). Infection and autoimmunity: A story of the host, the pathogen, and the copathogen. Clin. Immunol. Inwumopatliol. 74(1), 10-22.
74. Kuchroo, V. K., Das, M. P., Brown, J. A., Ranger, A. M., Zamvil, S. S., Sobel, R. A., Weiner, H. L., Nabovi, N., and Glimcher, L. H. (1995). B7-1 and B7-2 costimulatory and molecules activate differentially the Th1/Th2 developmental pathways: Application to autoimmune therapy. Cell (Cambridge, Mass.) 80, 707-718.
75. Kumar, V., Bhardwaj, V., Soares, L., Alexander, J., Sette, A., and Sercarz, E. (1995). Major histocompatibility complex binding affinity of an antigenic determinant is crucial for the differential secretion of interleukin 4/5 or interferon-γ by T cells. Proc. Natl. Acad. Sei. U.S.A. 92, 9510-9514.
76. Laman, J. D., Claassen, E., and Noelle, R. J. (1996). Functions of CD40 and its ligand, gp39 (CD40L). Crit. Rev. Immunol. 16, 59-108.
77. Lamont, A. G., and Adorini, L. (1996). IL-12: A key cytokine in immune regulation. Immunol. Today 17, 214-217.
78. Lehmann, P. V., Forsthuber, T., Miller, A., and Sercarz, E. E. (1992). Spreading of T-cell autoimmunity to cryptic determinants of an autoantigen. Nature (London) 358, 155-157.
79. Lenschow, D. J., Ho, S. C., Sattar, H., Rhee, L., Gray, G., Nabavi, N., Herold, K. C, and Bluestone, J. A. (1995). Differential effects of anti-B7-1 and anti-B7-2 monoclonal antibody treatment on the development of diabetes in the nonobese diabetic mouse. J. Exp. Med. 181, 1145-1155.
80. Levine, S. J. (1992). The role of reactive oxygen species in the pathogenesis of multiple sclerosis. Med. Hypotheses 39, 271-274.
81. Liebert, U. G., Linington, C, and ter Meulen, V. (1988). Induction of autoimmune reactions to myelin basic protein in measles encephalitis in lewis rats. J. Neuroimmunol. 17,103-118.
82. Linington, C, Engelhardt, B., Kapoc, G., and Lassmann, H. (1992). The induction of persistently demyelinated lesions in the rat following repeated transfer of encephalitogenic T cell and demyelinating antibody. J. Neuroimmunol. 40, 19-224.
83. Lotze, M. T., Rubin, J. T., Carty, S., Edington, H., Person, P., Landreneau, R., Pippin, B., Posner, M., Rosenfelder, D., and Watson, C. (1994). Gene therapy of cancer: a pilot study of IL-4-gene-modified fibroblasts admixed with autologous tumor to elicit an immune response. Hum. Gene Ther. 5, 41-55.
84. Martin, R., and McFarland, H. F. (1995). Immunological aspects of experimental allergic encephalomyelitis and multiple sclerosis. Crit. Rev. Clin. Lab. Sei. 32, 121-182.
85. Martin, R., McFarland, H. F., and McFarlin, D. E. (1992). Immunological aspects of demyelinating disease. Annu. Rev. Immunol. 10, 153-187.
86. Matzinger, P. (1994). Tolerance, danger and the extended family. Anna. Rev. Immunol. 12, 991-1045.
87. McCombe, P. A. (1995). Autoimmune diseases of the neuromuscular junction and other disorders of the motor unit. In "Autoimmune Neurological Disease" (M. P. Pender and P. A. McCombe, eds.), pp. 257-330. Cambridge University Press, Cambridge, UK.
88. McFarland, H. F. (1996). Complexities in the treatment of autoimmune disease. Science 274, 2037-1709.
89. McRae, B. L., Vanderlugt, C. L., Dal Canto, M. C., and Miller, S. D. (1995). Functional evidence for epitope spreading in the relapsing pathology of experimental allergic encephalomyelitis. J. Exp. Med. 182, 75-85.
90. Miller, A., Lider, O., and Weiner, H. L. (1991). Antigen driven bystander suppression following oral administration of antigen. J. Exp. Med. 174, 781-798.
91. Miller, S. D., Wetzig, R. P., and Claman, H. N. (1979). The induction of cell-mediated immunity and tolerance with protein coupled to syngeneic lymphoid cells. J. Exp. Med. 149,758-762.
92. Miller, S. D., McRae, B. L., Vanderlugt, C. L., Nikcevich, K. M., Pope, J. G., Pope, L., and Karpus, W. J. (1995). Evolution of the T-cell repertoire during the course of experimental immune-mediated demyelinating diseases. Immunol. Rev. 144, 225-244.
93. Morris, M. M., Dyson, H., Baker, D., Harbige, L. S., Fazakerely, J. K., and Amor, S. (1997). Characterization of the cellular and cytokine response in the central nervous system follow-ing Semliki Forest virus infection. J. Neuroimmunol 74,185-197.
94. Mossman, T. R., and Coffman, R. L. (1989). Th1 and Th2 cells: Different patterns of lymphokine secretion lead to different functional properties. Annu. Rev. Immunol. 7, 145-173.
95. Mueller, D. L., Jenkins, M. K., and Schwartz, R. H. (1989). Clonal expansion versus clonal inactivation: A costimulatory signalling pathway determines the outcome of T cell antigen receptor occupancy. Annu. Rev. Immunol. 1, 445-480.
96. Multiple Sclerosis Genetics Group (1996). A complete genomic screen for multiple sclerosis underscores a role for the major histocompatibility complex. Nat. Genet. 13, 469-471.
97. Nagata, S., and Goldstein, P. (1995). The Fas death factor. Science 267, 1149-1456.
98. Paliard, X., West, S. G., Lafferty, J. A., Clements, J. R., Kappler, J. W., Marrack, P., and Kotzin, B. L. (1991). Evidence for the effects of superantigen in rheumatoid arthritis. Science 253, 325-329.
99. Pei, D., and Weiss, S. J. (1995). Furin-dependent intracellular activation of the human stromelysin-3 zymogen. Nature (London) 375, 244-247.
100. Pender, M. P. (1995). Experimental autoimmune encephalomyelitis. In "Autoimmune Neurological Disease" (M. P. Pender and P. A. McCombe, eds.), pp. 26-88. Cambridge University Press, Cambridge, UK.
101. Potter, K. N. (1980). Comparison of vesicular stomatitis virus defective interfering particle synthesis in chick embryo and L cells. Can. J. Microbiol. 25, 1458-1463.
102. Racke, M. K., Quigley, L., Cannella, B., Raine, C. S., McFarlin, D. E., and Scott, D. E. (1994). Superantigen modulation of experimental allergic encephalomyelitis. J. Immunol. 152, 2051-2059.
103. Racke, M. K., Scott, D. E., Quigley, L., Gray, G. S., Abe, R., June, C. H., and Perrin, P. J. (1995). Distinct roles for B7-1 (CD80) and B7-2 (CD86) in the initiation of experimental allergic encephalomyelitis. J. Clin. Invest. 96, 2195-2203.
104. Racke, M. K., Critchfield, J. M., Quigley, L., Cannella, B., Raine, C. S., McFarland, H. F., and Lenardo, M. J. (1996). Intravenous antigen administration as a therapy for autoimmune demyelinating disease. Ann. Neural. 39, 46-56.
105. Rocken, M., Racke, M., and Shevach, E. M. (1996). IL-4-induced immune deviation as antigen specific therapy for inflammatory autoimmune disease. Immunol. Today 17, 225-231.
106. Rose, N. R., and Bona, C. (1993). Defining criteria for autoimmune diseases (Witebsky's postulates revisited). Immunol. Today 14, 426-429.
107. Russell, J. H., White, C. L., Loh, D. Y., and Meleedy-Rey, P. (1991). Receptor-stimulated death pathway is opened by antigen in mature T cells. Proc. Natl. Acad. Sei. U.S.A. 88,2151-2155.
108. Russell, W. C. (1997). Viruses and MS. In "Molecular Biology of Multiple Sclerosis" (W. C. Russell, ed.), pp. 243-254. Wiley, Chichester.
109. Sadovnik, A. D., and Ebers, G. C. (1993). Epidemiology of multiple sclerosis: A critical review. Can. J. Neural. Sei. 20, 17-29.
110. Saida, K., Saida, T., Pleasure, D. E., and Nishitani, H. (1983). P2 protein-induced experimental allergic neuritis. J. Neural. Sei. 62, 77-93.
111. Savino, W., and Dardenne, M. (1995). Immune-neuroendocrine interactions. Immunol. Today 16, 318-322.
112. Sawcer, S., Jones, H. B., Feakes, R., Gray, J., Smaldon, N., Chataway, J., Robertson, N., Clayton, D., Goodfellow, P. N., and Compston, A. (1996). A genome screen in multiple sclerosis reveals susceptibility loci on chromosome 6p21 and 17q22. Nat. Genet. 13,464-468.
113. Scherer, M. T., Ignatowicz, L., Winslow, G. M., Kappler, J. W., and Marrack, P. (1993). Superantigens: Bacterial and viral proteins that manipulate the immune system. Annu. Rev. Cell Biol. 9, 101-128.
114. Schwartz, R. H. (1992). Costimulation of T lymphocytes: The role of CD28, CTLA-4 and B7/ BB1 in interleukin-2 production and immunotherapy. Cell (Cambridge, Mass.) 71, 1065-1068.
115. Sercarz, E. E., Lehman, P. V., Ametani, A., Benichou, G., Miller, A., and Moudgil, K. (1993). Dominance and crypticity of T cell antigenic determinants. Annu. Rev. Immunol. 11, 729-766.
116. Serreze, D. V., and Leiter, E. H. (1994). Genetic and pathogenic basis of autoimmune diabetes in NOD mice. Curr. Opin. Immunol. 6, 900-906.
117. Sloan-Lancester, J., Evavold, B. D., and Allen, P. M. (1993). Induction of T-cell anergy by altered peptide ligand on live antigen-presenting cells. Nature (London) 363, 156-159.
118. Sloan-Lancester, J., Evavold, B. D., and Alien, P. M. (1994). Th2 cell clonal anergy as a consequence of partial activation. J. Exp. Med. 180, 1195-1205.
119. Song, Y-H., Li, Y., and Maclaren, N. K. (1996). The nature of autoantigens targeted in autoimmune endocrine diseases. Immunol. Today 17, 232-238.
120. Springer, T. A. (1990). Adhesion receptors of the immune system. Nature (London) 346, 425-434.
121. Subak-Sharpe, I., Dyson, H., and Fazakerely, J. K. (1993). In vivo depletion of CD8+ T cells prevents lesions of demyelination in Semliki Forest virus infection. J. Virol. 67,7629-7633.
122. Sundvall, M., Jirholt, J., and Yang, H.-T. (1995). Identification of murine loci associated with susceptibility to chronic experimental autoimmune encephalomyelitis. Nat. Genet. 10, 313-317.
123. Swank, R. L., Lerstad, O., Strøm, A., and Backer, J. (1952). Multiple sclerosis in rural Norway. N. Engl J. Med. 246, 721-728.
124. Swierkosz, J. E., and Swanborg, R. H. (1977). Immunoregulation of experimental allergic encephalomyelitis: Conditions for induction of suppressor cells and analysis of mechanism. J. Immunol. 119, 1501-1507.
125. 2. J. Neuroimmunol. 8,153-157.
126. Theofilopoulos, A. N. (1992). Murine models of Lupus. In "Systemic Lupus Erthyematosus" (R. G. Lahita, ed.), pp. 121-194. Churchill-Livingstone, New York.
127. Theofilopoulos, A. N. (1995). The basis of autoimmunity. Part II. Genetic predisposition. Immunol. Today 16, 150-159.
128. Todd, J. A. (1995). Genetic analysis of type I diabetes using whole genome approaches. Proc. Nat. Acad. Sei. U.S.A. 92, 8560-8565.
129. Trentham, D. E., Dynesius-Trentham, R. A., Orav, E. J., Combitchi, D., Lorenzo, C, Sewall, K. L., Hafler, D. A., and Weiner, H. L. (1993). Effects of oral administration of type II collagen on rheumatoid arthritis. Science 261, 1727-1730.
130. Trinchieri, G., and Scott, P. (1994). The role of interleukin 12 in the immune response, disease and therapy. Immunol. Today, 15, 460-463.
131. Urban, J. L., Kumar, V., Kono, D. H., Gomez, C, Horvah, S. J., Clayton, J., Ando, D. G., Sercarz, E. E., and Hood, L. (1988). Restricted use of T cell receptor V genes in murine autoimmune encephalomyelitis raises possibilities for antibody therapy. Cell (Cambridge, Mass.) 54, 577-592.
132. Vandenbark, A. A., Hashim, G., and Offner, H. (1989). Immunization with a synthetic T-cell receptor V-region peptide protects against experimental encephalomyelitis. Nature (London) 341, 541-544.
133. Vandenbark, A. A., Chou, Y. K., Whitham, R., Mass, M., Buenafe, A., Liefeid, D., Kavanagh, D., Cooper, S., Hashim, G. A., Offner, H., and Bourdette, D. N. (1996). Treatment of multiple sclerosis with T-cell receptor peptides: Results of a double-blind pilot. Nat. Med. 2,1109-1115.
134. Van den Broek, M. F., Hogervorst, E. J. M., Van Bruggen, M. J. C, Van Eden, W., Van der Zee, R., and Van den Berg, W. B. (1989). Protection against streptococcal cell wall-induced arthritis by pretreatment with the 65-kD mycobacterial heat shock protein. J. Exp. Med. 170, 449-455.
135. Van Eden, W. (1991). Heat-shock proteins and the immune system. Immunol. Rev. 121,5-28.
136. Van Noort, J. M. (1996). Multiple sclerosis: An altered immune response or an altered stress response? J. Mol Med. 74, 285-296.
137. Van Noort, J. M., Anderton, S. M., Wagenaar, J. P. A., Wauben, M. H. W., van Holten, C, and Boog, C. J. P. (1994). Differential rat T-cell recognition of chathepsin D-released fragments of mycobacterial 65 kDa heat-shock protein after immunization with either the recombinant protein or whole mycobacteria. Int. Immimol. 4, 603-609.
138. Van Noort, J. M., van Sechel, A. C., Bajramovic, J. J., EI Ouagmiri, M., Polman, C. H., Lassmann, H., and Ravid, R. (1995). The small heat shock protein alpha B-crystallin as a candidate autoantigen in multiple sclerosis. Nature (London) 375, 798-801.
139. Van Sechel, A. C, Bajramovic, J. J., Verhulst, K. C, Geutskens, S. B., and Van Noort, J. M. (1997). Activation of autoreactive helper T cells by virus-induced presentation of a self antigen. Submitted.
140. Van Stipdonk, M. J. B., Borsboom, A. A., Amor, S., Persoon-Deen, C., Verzaal, P., Travers, P., Boog, C. J. P., and Van Noort, J. M. (1997). T cells discriminate between differentially phosphorylated forms of aB-crystallin, a major myelin antigen. Submitted.
141. Van Wart, H. E., and Birkedal-Hansen, H. (1990). The cysteine switch: A principle of regulation of metalloproteinase activity with potential application to the entire matrix metalloproteinase gene family. Proc. Natl. Acad. Sei. U.S.A. 87, 5578-5582.
142. Vaux, D. L., Haecker, G., and Strasser, A. (1994). An evolutionary perspective on apoptosis. Cell (Cambridge, Mass.) 76, 777-779.
143. von Herrath, M. G., and Oldstone, M. B. (1995). Role of viruses in the loss of tolerance to self-antigens and in autoimmune diseases. Trends Microbiol. 3, 424-430.
144. Waisman, A., Ruiz, P. J., Hirschberg, D. L., Gelman, A., Oksenberg, J. R., Brocke, S., Mor, F., Cohen, I. R., and Steinman, L. (1996). Suppressive vaccination with DNA encoding a variable region gene of the T-cell receptor prevents autoimmune encephalomyelitis and activates Th2 immunity. Nat. Med. 2, 899-905.
145. Waksman, B. H. (1995). More genes versus environment. Nature (London) 377, 105-106.
146. Weiner, H. L., Mackin, G. A., Matsui, M., Orav, E. J., Khoury, S. J., Dawson, D. M., and Hafler, D. A. (1993). Double-blind pilot trial of oral tolerization with myelin antigens in multiple sclerosis. Science 259, 1321-1324.
147. Weiner, H. L., Friedman, A., Miller, A., Khoury, S. J., Al-Sabbagh, A., Santos, L., Sayegh, M., Nussenblatt, R. B., Trentham, D. E., and Hafler, D. A. (1994). Oral tolerance: Immunologic mechanisms and treatment of animal and human organ-specific autoimmune disease by oral administration of autoantigens. Annu. Rev. Iinnumol. 12, 809-837.
148. Weiss, G., Wachter, H., and Fuchs, D. (1995). Linkage of cell-mediated immunity to iron metabolism. Immunol. Today 16, 495-500.
149. Weiss, S., and Bogen, B. (1991). MHC class II-restricted presentation of intracellular antigen. Cell (Cambridge, Mass.) 64, 676-776.
150. Wilbanks, G. A., and Streilein, J. W. (1991). Studies on the induction of anterior-chamber associated immune deviation (ACAID). I. Evidence that an antigen-specific ACAID-inducing cell-associated signal exists in the peripheral blood. J. Immunol. 146, 2610-2615.
151. Wilcox, C. E., Healy, D. G., Baker, D., Willoughby, D. A., and Turk, J. L. (1989). Presentation of myelin basic protein by normal guinea-pig endothelial cells and it's relevance to experimental allergic encephalomyelitis. Immunology 76, 435-440.
152. Woodland, D. L., Wen, R., and Blackman, M. A. (1997). Why do superantigens care about peptides? Immunol. Today 18,18-22.
153. Wucherpfennig, K. W., and Strominger, J. L. (1995). Molecular mimicry in T-cell mediated autoimmunity: Viral peptides activate human T cell clones specific for myelin basic protein. Cell (Cambridge, Mass.) 80, 695-705.
154. Yu, M., Johnson, J. M., and Tuohy, V. K. (1996). A predictable sequential determinant spreading cascade invariable accompanies progression of experimental encephalomyelitis: A basis for peptide-specific therapy after onset of clinical disease. J. Exp. Med. 183,1777-1788.
155. Zamvil, S. S., and Steinman, L. (1990). The lymphocyte in experimental allergic encephalomy-elitis. Annu. Rev. Immunol 8, 579-621.
156. Zamvil, S. S., Mitchell, D. J., Lee, N. E., Moor, A. E., Waldor, K. M., Sakai, K., Rothbard, J. B., McDevitt, H. O., Steinman, L., and Acha-Orbea, H. (1988). Predominant expression of a T cell receptor V beta gene subfamily in autoimmune encephalomyelitis. J. Exp. Med. 167, 1586-1596.
157. Zhang, J., Medaer, R., Stinissen, P., Hafier, D. A., and Raus, J. C. M. (1993). MHC-restricted depletion of human myelin basic protein-reactive T cells by T-cell vaccination. Science 261, 1451-1454.
158. Zinkernagel, R. M., and Doherty, P. C. (1997). The discovery of MHC restriction. Immunol. Today 18, 14-17.